XTL Biopharmaceuticals Ltd (XTLB)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -249k | -202k | -204k | -225k | -251k | -163k | -151k | -200k |
| Pre Tax Income | 506k | -285k | -821k | -748k | -919k | -364k | -215k | -284k |
| Net Income | 72k | 149k | -821k | -748k | -919k | -364k | -215k | -284k |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -249k | -202k | -204k | -225k | -251k | -163k | -151k | -200k |
| EBITDA | -249k | -202k | -204k | -224k | -251k | -163k | -151k | -200k |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.56M | -1.24M | -793k | -842k | -948k | -1.03M | -880k | -765k |
| Pre Tax Income | -2.55M | -781k | 2.99M | -1.35M | -782k | 435k | -1.35M | -1.78M |
| Net Income | -2.55M | -781k | 2.99M | -1.35M | -782k | 435k | -1.35M | -1.78M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.008 | -0.001 | 0.005 | -0.002 | -0.001 | 0.001 | -0.002 | -0.003 |
| EBIT | -2.56M | -1.25M | -793k | -842k | -948k | -1.03M | -880k | -765k |
| EBITDA | -1.71M | -1.24M | -793k | -842k | -947k | -1.03M | -879k | -765k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
